Departments of *Psychiatry
†Neurology
‡Radiology
§Pharmacology
∥Biostatistics
¶Neuroscience, University of Pittsburgh, Pittsburgh, PA
Departments of ♯Radiology
**Neurology
††Psychiatry and Behavioral Science, Emory University, Atlanta, GA
Supported by PHS grants MH072947, MH67602, MH59945, MH64625, AG25516, AG25204, AG05133, MH43832, MH01210, AG01039, MH71944, MH070729 and MH52247, as well as the John A. Hartford Foundation Center of Excellence in Geriatric Psychiatry and UPMC Endowment in Geriatric Psychiatry.
Dr Reynolds receives research support (pharmaceutical supplies) from Glaxo Smith-Kline, Forest, Pfizer, Lilly, and Bristol Myers Squibb.
Reprints: Meryl A. Butters, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O'Hara St., Pittsburgh, PA 15213 (e-mail: [email protected]).
Received for publication January 15, 2007; accepted January 24, 2008
GE Healthcare holds a license agreement with the University of Pittsburgh based on the technology described in this manuscript. Drs Klunk and Mathis are co-inventors of PiB and, as such, have a financial interest in this license agreement. GE Healthcare provided no grant support for this study and had no role in the design or interpretation of results or preparation of this manuscript. All other authors have no conflicts of interest with this work. Drs Butters, Meltzer, Klunk, Mathis, Price, and DeKosky as well as Mr Ziolko had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
